Cancer therapeutics and biotherapeutic market Forecast to 2022 Cancer therapeutics and biotherapeutic market Fore | Page 2

Cancer Therapeutics and Biotherapeutic Market Overview
• Cancer is one of the leading causes of death worldwide. According to the World Health
Organization, about 8.2 million deaths occurred in 2012 due to cancer.
• The most common kinds of cancer which tend to result in death are lung cancer, liver
cancer, stomach cancer, colorectal cancer, breast cancer and oesophageal cancer.
• Apart from the mature chemotherapy market, biotherapy has emerged as a new
approach for cancer treatment.
• Biotherapy boosts the body’s immune system to slow or stop the growth of cancer cells.
• Growing demand for personalized medicine and the introduction of novel approaches
are expected to drive the market growth.
• Astra Zeneca PLC, Biogen IDEC, Bristol-Myers Squibb, Sanofi, Merck, Johnson & Johnson,
Schering-Plough and Roche are some players in this market.